Risk–benefit analysis on the clinical significance of convalescent plasma therapy in the management of COVID-19

Detalles Bibliográficos
Autores principales: Dhanasekaran, Sivaraman, Vajravelu, Leela Kagithakara, Venkatesalu, Venugopal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016903/
https://www.ncbi.nlm.nih.gov/pubmed/32817576
http://dx.doi.org/10.1136/postgradmedj-2020-138056
_version_ 1784907478883893248
author Dhanasekaran, Sivaraman
Vajravelu, Leela Kagithakara
Venkatesalu, Venugopal
author_facet Dhanasekaran, Sivaraman
Vajravelu, Leela Kagithakara
Venkatesalu, Venugopal
author_sort Dhanasekaran, Sivaraman
collection PubMed
description
format Online
Article
Text
id pubmed-10016903
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-100169032023-05-23 Risk–benefit analysis on the clinical significance of convalescent plasma therapy in the management of COVID-19 Dhanasekaran, Sivaraman Vajravelu, Leela Kagithakara Venkatesalu, Venugopal Postgrad Med J Letter Oxford University Press 2020-08-17 /pmc/articles/PMC10016903/ /pubmed/32817576 http://dx.doi.org/10.1136/postgradmedj-2020-138056 Text en © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by/4.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Letter
Dhanasekaran, Sivaraman
Vajravelu, Leela Kagithakara
Venkatesalu, Venugopal
Risk–benefit analysis on the clinical significance of convalescent plasma therapy in the management of COVID-19
title Risk–benefit analysis on the clinical significance of convalescent plasma therapy in the management of COVID-19
title_full Risk–benefit analysis on the clinical significance of convalescent plasma therapy in the management of COVID-19
title_fullStr Risk–benefit analysis on the clinical significance of convalescent plasma therapy in the management of COVID-19
title_full_unstemmed Risk–benefit analysis on the clinical significance of convalescent plasma therapy in the management of COVID-19
title_short Risk–benefit analysis on the clinical significance of convalescent plasma therapy in the management of COVID-19
title_sort risk–benefit analysis on the clinical significance of convalescent plasma therapy in the management of covid-19
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016903/
https://www.ncbi.nlm.nih.gov/pubmed/32817576
http://dx.doi.org/10.1136/postgradmedj-2020-138056
work_keys_str_mv AT dhanasekaransivaraman riskbenefitanalysisontheclinicalsignificanceofconvalescentplasmatherapyinthemanagementofcovid19
AT vajraveluleelakagithakara riskbenefitanalysisontheclinicalsignificanceofconvalescentplasmatherapyinthemanagementofcovid19
AT venkatesaluvenugopal riskbenefitanalysisontheclinicalsignificanceofconvalescentplasmatherapyinthemanagementofcovid19

Ejemplares similares